India is ranked as the third largest pharmaceutical market in terms of volumes and 14th by value simply translating that the country produces more copycat drugs than the innovator medications
Read More
Telemedicine is plateauing as a business model, especially for new entrants in the service. Yet in a country where a vast multitude still has no access to specialist care, tele-consultations could fill an awning gap in healthcare services. An In Depth report on healthtech and its prospects
Read More
Raising funds will never be a challenge for Sankara Foundation, as when you have multiple hands raised together in support
Read More
A stellar stock market debut, robust financial performance, growth expectations and new drug launches – there is a lot going on for Mankind Pharma
Read More
An open offer for the remaining 26 per cent of stake will be triggered within stipulated timelines and the required details will be announced soon
Read More
Know how Aarti Gill, the co-founder & CEO of OZiva, transformed nutrition, pioneering plant-based innovation for a healthier India
Read More
The expansion plan comprises the construction of 16.5 lakh sq ft of cutting-edge research laboratories spread over 17.5 acre
Read More
Indonesia minister Sadikin, after the visit to a Jan Aushadi Kendra, said, "I want to give the best medicines to my people in Indonesia. I have seen many models of different countries, and India's Jan Aushadhi Kendra model is the best in the world in terms of providing quality, accessibility and affordability of medicines to the people"
Read More
In India, the Danish drug maker Novo Nordisk is the market leader and presently claims around 60 per cent of the country’s insulin supply. Speaking to BW Businessworld in an exclusive interaction, John C Dawber, CVP and MD, Global Business Services talks about the company’s GLP1 growth story, the market of obesity drugs and their safety profile and building capacities and partnerships
Read More
According to a 2019 report by Health Care Without Harm (HCWH), the global healthcare sector’s climate footprint is equivalent to 4.4 per cent of global net emissions, contributing around 2 gigatonnes of carbon dioxide into the environment
Read More
